Speaking Engagement

Exploring the Expedited Approval Process: Applicability and Eligibility

ACI's 35th FDA Boot Camp

23 Mar 2020 10:30 a.m. - 11:15 a.m.

DoubleTree By Hilton Metropolitan
569 Lexington Ave
New York, NY 10022

Bethany Hills is speaking at the FDA bootcamp in NYC in March.

  • Understanding accelerated approval, breakthrough therapy, surrogate end points, and biomarkers
  • Reviewing the different pathways for expedited approval
    • Evaluating the criteria for each pathway
    • Weighing the pros and cons of each pathway
  • Factoring expedited approval into your drug development strategy
  • Discussing the limitations that exist for orphan and breakthrough drugs
  • Obtaining waivers for rare diseases



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.